Charles Schwab Investment Management Inc. Sells 13,963 Shares of Aemetis, Inc. (NASDAQ:AMTX)

Charles Schwab Investment Management Inc. lowered its position in Aemetis, Inc. (NASDAQ:AMTX) by 14.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 85,413 shares of the specialty chemicals company’s stock after selling 13,963 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Aemetis were worth $196,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Susquehanna Fundamental Investments LLC grew its position in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after buying an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Aemetis during the 2nd quarter valued at about $306,000. Rhumbline Advisers grew its holdings in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares in the last quarter. Finally, Hutchinson Capital Management CA purchased a new position in shares of Aemetis during the second quarter worth about $70,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Price Performance

NASDAQ:AMTX opened at $2.69 on Friday. The company has a market capitalization of $133.79 million, a price-to-earnings ratio of -1.19 and a beta of 1.35. The business has a 50 day moving average of $3.30 and a 200 day moving average of $3.01. Aemetis, Inc. has a 1-year low of $2.10 and a 1-year high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to analysts’ expectations of $77.79 million. During the same period last year, the company posted ($0.59) EPS. As a group, sell-side analysts anticipate that Aemetis, Inc. will post -2.02 EPS for the current year.

Wall Street Analyst Weigh In

AMTX has been the topic of a number of recent analyst reports. Ascendiant Capital Markets lowered their target price on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. HC Wainwright restated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.